Publication | Closed Access

Serial 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)

Positron Emission TomographyBreast OncologyBone ImagingOncologic ImagingMedicineBreast CancerRadiation OncologyOncologyNuclear MedicineMolecular ImagingRadiologyHealth Sciences